Mechanical performances of finger jointed cross laminated timber (CLT)

Based on the idea of first producing small-size CLT panels and afterward connecting them using finger joints to make larger CLT panels, finger-jointed CLT test specimens were fabricated by setting experimental parameters such as the kind of finger joint (large or normal), the combination of finger joint strength (strong–strong, or weak–weak) and the number of layers, and ply (3L3P, 5L5P, and 5L7P). Destructive tests subjected to out-of-plane as well as in-plane bending and shear, and axial compression load were performed. To judge the mechanical performance of the finger-jointed CLT panels, the lower 5% strength value evaluated from the destructive tests data were used for comparison with the characteristic strength value of CLT products assigned by the Ministry of Land, Infrastructure, Transport and Tourism in Japan (MLIT). On the other hand, the lower 50% stiffness value evaluated from the destructive test data was used for comparison with the design stiffness values proposed by commercial sectors. Most of the tested finger-jointed CLT groups satisfied the requirements for the characteristic strength values although there were a few exceptional cases in the weak–weak groups. All of the tested finger jointed CLT groups satisfied the proposed design stiffness values

Silent cerebral infarction predicts vascular events in hemodialysis patients

Silent cerebral infarction predicts vascular events in hemodialysis patients.BackgroundCardiovascular disease is the leading cause of death in hemodialysis (HD) patients. We have previously reported a higher incidence of silent cerebral infarction (SCI) in HD patients compared with the control group using MRI studies. In the present study, we examined whether or not SCI could predict vascular events in HD patients.MethodsCranial magnetic resonance imaging (MRI) was performed on 119 HD patients without symptomatic cerebrovascular disease. SCI was detected by MRI, and the patients were prospectively followed up. The end points of the study were the incidence of major events related to vascular events (cerebral events, cardiac events, and sudden deaths). We investigated the prognostic role of SCI in cerebral, cardiac, and vascular events by using the Kaplan-Meier method and Cox proportional hazards analysis.ResultsThe prevalence of SCI was 49.6% in HD patients. During a follow-up period of maximum 60 months, vascular events, which included 13 cerebral events, 5 cardiac events, and 3 sudden deaths, occurred in 21 patients. The presence of SCI was predictive for a higher cerebral and vascular morbidity compared to the absence of SCI [18.6% (N = 11) vs. 3.3% (N = 2), P = 0.0169, and 30.5% (N = 18) vs. 5.0% (N = 3), P = 0.0006, respectively]. By multivariate Cox proportional hazards analysis, SCI remained a powerful independent predictor of cerebral and vascular events (hazard ratio for cerebral events 7.33, 95% CI 1.27–42.25: for vascular events 4.48, 95% CI 1.09–18.41).ConclusionThe findings of the present study indicate that the presence of SCI is a new risk factor for vascular events in HD patients

Positional differences of intronic transposons in pAMT affect the pungency level in chili pepper through altered splicing efficiency

トウガラシの辛味レベルを変化させる遺伝子変異を発見 －激辛・中辛・辛くないを作り分ける－. 京都大学プレスリリース. 2019-08-30.Capsaicinoids are unique compounds that give chili pepper fruits their pungent taste. Capsaicinoid levels vary widely among pungent cultivars, ranging from low‐pungency to extremely pungent. However, the molecular mechanisms underlying its quantitative variation have not been elucidated. Our previous study identified various loss‐of‐function alleles of the pAMT gene, which led to low‐pungency. The mutations in these alleles are commonly defined by Tcc transposon insertion and its footprint. In this study, we identified two leaky pamt alleles (pamtL1 and pamtL2) with different levels of pAMT activity. Notably, both alleles had a Tcc transposon insertion in intron 3, but the locations of the insertions within the intron were different. Genetic analysis revealed that pamtL1, pamtL2 and a loss‐of‐function pamt allele reduced capsaicinoid levels to about 50%, 10%, and less than 1%, respectively. pamtL1 and pamtL2 encoded functional pAMT proteins, but they exhibited lower transcript levels compared with the functional‐type. RNA‐seq analysis showed that intronic transposons disrupted splicing in intron 3, which resulted in simultaneous expression of functional pAMT mRNA and non‐functional splice variants containing partial sequences of Tcc. The non‐functional splice variants were more dominant in pamtL2 than that in pamtL1. This suggested that the difference in position of the intronic transposons could alter splicing efficiency, which led to different pAMT activities and reduced capsaicinoid content to different levels. Our results provide a striking example where intronic transposons caused allelic variations, which contributed to quantitative differences in secondary metabolite contents

Micro Scanning Laser Range Sensor for Planetary Exploration

This paper proposes a new type of scanning laser range sensor for planetary exploration. The proposed sensor has advantages of small size, light weight, and low power consumption with the help of micro electrical mechanical systems technology. We are in the process of developing a miniature two dimensional optical sensor which is driven by a piezoelectric actuator. In this paper, we present the mechanisms and system concept of a micro scanning laser range sensor

Attitudes toward and current status of disclosure of secondary findings from next-generation sequencing: a nation-wide survey of clinical genetics professionals in Japan

The management of secondary findings (SFs), which are beyond the intended purpose of the analysis, from clinical comprehensive genomic analysis using next generation sequencing (NGS) presents challenges. Policy statements regarding their clinical management have been announced in Japan and other countries. In Japan, however, the current status of and attitudes of clinical genetics professionals toward reporting them are unclear. We conducted a questionnaire survey of clinical genetics professionals at two time points (2013 and 2019) to determine the enforcement of the SF management policy in cases of comprehensive genetic analysis of intractable diseases and clinical cancer genome profiling testing. According to the survey findings, 40% and 70% of the respondents stated in the 2013 and 2019 surveys, respectively, that they had an SF policy in the field of intractable diseases, indicating that SF policy awareness in Japan has changed significantly in recent years. Furthermore, a total of 80% of respondents stated that their facility had established a policy for clinical cancer genome profiling testing in the 2019 survey. In both surveys, the policies included the selection criteria for genes to be disclosed and the procedure to return SFs, followed by recommendations and proposals regarding SFs in Japan and other countries. To create a better list of the genes to be disclosed, further examination is needed considering the characteristics of each analysis